Metropolis Healthcare, 542650, METROPOLIS Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

8,791.30
60.64
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

8,756.47
N/A
6.61

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

10.26
7.12
-0.56

EBITDA CAGR (%)

10 Years
5 Years
3 Years

9.38
3.96
-3.59

PAT CAGR (%)

10 Years
5 Years
3 Years

7.69
0.68
-15.81

P:E (Median)

8 Years
5 Years
3 Years

-
61.05
56.47

P:BV (Average)

8 Years
5 Years
3 Years

-
11.50
7.96

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
32.09
27.30

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 24.95 28.29 39.54 49.26
P/E Ratio 67.99 59.96 42.90 34.44
Revenue 1208 1331 1650 1862
EBITDA 283 303 400 470
Net Income 128 145 204 254
ROA 8.4 8.5 11.5 13.1
P/B Ratio 8.43 6.60 6.02 5.30
ROE 12.26 11.95 15.03 16.47
FCFF 210 202 207 287
FCFF Yield 2.4 2.31 2.37 3.28
Net Debt 73 86 -170 -359
BVPS 201.3 256.94 281.71 320.21

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 311.95 292.27 6.73% 296.88 269.41 10.20% 321.57 285.46 12.65% 286.14 256.29 11.65%
Expenses 259.21 218.34 18.72% 231.78 210.58 10.07% 239.55 217.98 9.90% 217.87 198.03 10.02%
EBITDA 52.74 73.92 -28.65% 65.10 58.83 10.66% 82.02 67.47 21.57% 68.27 58.26 17.18%
EBIDTM 16.91% 25.29% 21.93% 21.83% 25.51% 23.64% 23.86% 22.73%
Other Income 7.60 2.02 276.24% 3.03 5.19 -41.62% 3.59 2.01 78.61% 2.83 2.78 1.80%
Interest 4.43 5.65 -21.59% 4.49 5.24 -14.31% 4.73 5.62 -15.84% 4.61 5.83 -20.93%
Depreciation 27.28 25.24 8.08% 26.85 24.14 11.23% 26.01 21.37 21.71% 24.76 19.99 23.86%
PBT 28.63 45.05 -36.45% 36.80 34.63 6.27% 54.87 42.49 29.14% 41.72 35.23 18.42%
Tax 4.78 13.27 -63.98% 9.40 7.93 18.54% 12.60 11.21 12.40% 10.44 9.10 14.73%
PAT 23.85 31.78 -24.95% 27.41 26.70 2.66% 42.26 31.28 35.10% 31.28 26.13 19.71%
PATM 7.65% 10.87% 9.23% 9.91% 13.14% 10.96% 10.93% 10.20%
EPS 4.60 6.14 -25.08% 5.29 5.15 2.72% 8.16 6.04 35.10% 6.04 5.05 19.60%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 345.29 331.00 4.32% 322.77 291.12 10.87% 349.79 308.50 13.38% 313.36 277.09 13.09%
Expenses 283.00 251.02 12.74% 250.76 226.27 10.82% 259.91 233.69 11.22% 234.54 214.15 9.52%
EBITDA 62.30 79.98 -22.11% 72.01 64.85 11.04% 89.88 74.81 20.14% 78.81 62.94 25.21%
EBIDTM 18.04% 24.16% 22.31% 22.28% 25.69% 24.25% 25.15% 22.71%
Other Income 6.97 2.54 174.41% 2.56 2.31 10.82% 3.13 1.22 156.56% 2.46 3.05 -19.34%
Interest 4.60 5.57 -17.41% 4.53 5.31 -14.69% 4.79 5.68 -15.67% 4.65 5.98 -22.24%
Depreciation 28.63 26.42 8.36% 27.70 24.99 10.84% 26.82 22.24 20.59% 25.54 20.82 22.67%
PBT 36.04 50.53 -28.68% 42.34 36.86 14.87% 61.40 48.11 27.62% 51.08 39.19 30.34%
Tax 6.81 14.01 -51.39% 10.86 9.57 13.48% 14.70 12.45 18.07% 12.97 10.21 27.03%
PAT 29.23 36.52 -19.96% 31.47 27.29 15.32% 46.70 35.66 30.96% 38.11 28.98 31.50%
PATM 8.47% 11.03% 9.75% 9.37% 13.35% 11.56% 12.16% 10.46%
EPS 5.63 7.11 -20.82% 6.12 5.30 15.47% 9.08 6.92 31.21% 7.41 5.62 31.85%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,216.54 1,103.43 1,066.04 1,157.01 961.39 665.31 581.21 484.95 355.95 304.40 254.74 Net Sales Growth 10.25% 3.51% -7.86% 20.35% 44.50% 14.47% 19.85% 36.24% 16.93% 19.49% Cost Of Goods Sold 244.48 220.48 235.55 261.60 244.23 167.25 139.08 111.64 91.41 82.62 70.81 Gross Profit 972.06 882.95 830.49 895.41 717.15 498.06 442.13 373.32 264.54 221.78 183.93 GP Margin 79.90% 80.02% 77.90% 77.39% 74.60% 74.86% 76.07% 76.98% 74.32% 72.86% 72.20% Total Expenditure 948.41 840.03 794.56 832.71 676.52 489.25 433.74 348.47 246.99 216.08 181.56 Power & Fuel Cost - 15.04 13.50 12.84 11.52 9.16 7.44 6.76 5.58 4.81 4.06 % Of Sales - 1.36% 1.27% 1.11% 1.20% 1.38% 1.28% 1.39% 1.57% 1.58% 1.59% Employee Cost - 246.60 228.16 218.24 188.24 147.67 136.95 109.72 84.16 70.04 54.67 % Of Sales - 22.35% 21.40% 18.86% 19.58% 22.20% 23.56% 22.63% 23.64% 23.01% 21.46% Manufacturing Exp. - 40.72 29.57 31.36 25.63 19.66 15.15 14.30 5.97 6.95 6.31 % Of Sales - 3.69% 2.77% 2.71% 2.67% 2.96% 2.61% 2.95% 1.68% 2.28% 2.48% General & Admin Exp. - 293.45 277.09 301.99 176.66 125.45 126.65 97.10 56.60 48.02 43.08 % Of Sales - 26.59% 25.99% 26.10% 18.38% 18.86% 21.79% 20.02% 15.90% 15.78% 16.91% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 23.75 10.70 6.68 30.23 20.07 8.48 8.96 3.27 3.63 0.00 % Of Sales - 2.15% 1.00% 0.58% 3.14% 3.02% 1.46% 1.85% 0.92% 1.19% 1.03% EBITDA 268.13 263.40 271.48 324.30 284.87 176.06 147.47 136.48 108.96 88.32 73.18 EBITDA Margin 22.04% 23.87% 25.47% 28.03% 29.63% 26.46% 25.37% 28.14% 30.61% 29.01% 28.73% Other Income 17.05 12.00 23.72 16.15 12.31 29.32 20.52 15.63 21.67 41.08 3.93 Interest 18.26 27.25 31.29 24.54 11.26 10.01 3.37 2.88 1.36 1.26 1.87 Depreciation 104.90 90.73 84.96 60.26 43.78 30.85 15.44 13.97 10.84 10.39 10.30 PBT 162.02 157.41 178.95 255.65 242.13 164.52 149.19 135.26 118.44 117.75 64.94 Tax 37.22 41.52 40.00 72.01 59.48 27.94 47.73 39.51 39.15 32.24 21.67 Tax Rate 22.97% 26.38% 22.35% 26.52% 24.57% 19.96% 31.99% 29.21% 33.05% 29.30% 33.37% PAT 124.80 115.89 138.95 199.53 182.65 112.05 101.46 95.76 79.29 77.80 43.28 PAT before Minority Interest 124.80 115.89 138.95 199.53 182.65 112.05 101.46 95.76 79.29 77.80 43.28 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 10.26% 10.50% 13.03% 17.25% 19.00% 16.84% 17.46% 19.75% 22.28% 25.56% 16.99% PAT Growth 7.69% -16.60% -30.36% 9.24% 63.01% 10.44% 5.95% 20.77% 1.92% 79.76% EPS 24.09 22.37 26.82 38.52 35.26 21.63 19.59 18.49 15.31 15.02 8.36

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,331.21 1,207.71 1,148.21 1,228.34 997.99 856.41 761.18 647.16 544.72 524.02 454.72 Net Sales Growth 10.23% 5.18% -6.52% 23.08% 16.53% 12.51% 17.62% 18.81% 3.95% 15.24% Cost Of Goods Sold 268.69 242.57 253.26 276.02 252.16 204.13 173.51 145.90 135.10 143.33 129.21 Gross Profit 1,062.52 965.14 894.95 952.31 745.82 652.27 587.67 501.27 409.62 380.69 325.51 GP Margin 79.82% 79.91% 77.94% 77.53% 74.73% 76.16% 77.21% 77.46% 75.20% 72.65% 71.58% Total Expenditure 1,028.21 919.78 857.10 882.67 708.20 619.27 557.23 468.69 391.23 387.93 337.21 Power & Fuel Cost - 16.20 14.43 14.73 12.00 12.49 11.00 9.99 9.12 9.03 8.15 % Of Sales - 1.34% 1.26% 1.20% 1.20% 1.46% 1.45% 1.54% 1.67% 1.72% 1.79% Employee Cost - 275.78 252.73 233.17 198.64 190.16 176.21 147.37 127.69 115.71 94.91 % Of Sales - 22.83% 22.01% 18.98% 19.90% 22.20% 23.15% 22.77% 23.44% 22.08% 20.87% Manufacturing Exp. - 46.05 31.30 48.35 34.23 22.51 19.24 18.84 10.86 8.93 13.26 % Of Sales - 3.81% 2.73% 3.94% 3.43% 2.63% 2.53% 2.91% 1.99% 1.70% 2.92% General & Admin Exp. - 307.81 289.77 300.57 177.98 167.62 166.23 132.17 101.87 101.19 85.00 % Of Sales - 25.49% 25.24% 24.47% 17.83% 19.57% 21.84% 20.42% 18.70% 19.31% 18.69% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 31.37 15.60 9.83 33.19 22.37 11.03 14.43 6.59 9.74 0.00 % Of Sales - 2.60% 1.36% 0.80% 3.33% 2.61% 1.45% 2.23% 1.21% 1.86% 1.47% EBITDA 303.00 287.93 291.11 345.67 289.79 237.14 203.95 178.47 153.49 136.09 117.51 EBITDA Margin 22.76% 23.84% 25.35% 28.14% 29.04% 27.69% 26.79% 27.58% 28.18% 25.97% 25.84% Other Income 15.12 9.12 17.46 20.03 12.05 8.57 8.21 7.77 25.59 21.80 6.01 Interest 18.57 27.89 31.85 25.02 11.56 12.65 4.12 3.54 1.94 1.62 2.16 Depreciation 108.69 94.47 89.22 63.22 45.94 39.27 20.07 19.02 17.23 20.54 20.52 PBT 190.86 174.69 187.50 277.45 244.32 193.78 187.98 163.68 159.92 135.73 100.84 Tax 45.34 46.23 44.11 78.67 60.97 41.18 62.94 51.84 52.66 46.09 33.04 Tax Rate 23.76% 26.46% 23.53% 26.82% 24.95% 24.33% 33.48% 31.67% 32.93% 36.00% 32.76% PAT 145.51 127.82 142.88 214.19 183.10 127.84 121.58 104.23 107.26 73.62 60.93 PAT before Minority Interest 144.97 128.46 143.39 214.69 183.35 128.07 125.04 111.84 107.26 81.93 67.80 Minority Interest -0.54 -0.64 -0.51 -0.50 -0.25 -0.23 -3.46 -7.61 0.00 -8.31 -6.87 PAT Margin 10.93% 10.58% 12.44% 17.44% 18.35% 14.93% 15.97% 16.11% 19.69% 14.05% 13.40% PAT Growth 13.28% -10.54% -33.29% 16.98% 43.23% 5.15% 16.65% -2.82% 45.69% 20.83% EPS 28.09 24.68 27.58 41.35 35.35 24.68 23.47 20.12 20.71 14.21 11.76

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,031.19 936.02 839.21 664.81 512.38 415.40 364.03 266.75 220.05 306.07 Share Capital 10.25 10.24 10.23 10.22 10.13 10.04 9.54 9.54 9.54 9.86 Total Reserves 1,013.21 918.43 817.18 646.06 500.19 402.78 352.78 257.16 210.51 296.21 Non-Current Liabilities 226.35 417.26 491.93 113.78 166.30 141.21 78.43 20.40 -0.86 5.43 Secured Loans 0.00 28.61 158.68 0.00 0.00 0.00 0.00 0.00 0.00 3.65 Unsecured Loans 0.00 2.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 34.72 185.06 170.93 43.68 133.39 133.13 70.75 2.54 2.41 1.92 Current Liabilities 263.13 290.50 347.89 222.04 153.67 183.12 164.35 232.81 71.49 45.53 Trade Payables 93.40 85.72 94.23 95.49 70.90 36.05 26.52 21.08 18.52 15.04 Other Current Liabilities 115.14 98.73 80.61 71.67 57.36 39.25 31.66 92.86 28.19 27.52 Short Term Borrowings 0.00 51.52 99.87 0.00 0.00 17.34 0.00 0.00 0.00 0.00 Short Term Provisions 54.59 54.53 73.18 54.88 25.41 90.47 106.18 118.88 24.78 2.96 Total Liabilities 1,520.67 1,643.78 1,679.03 1,000.63 832.35 739.73 606.81 519.96 290.68 357.03 Net Block 1,120.09 1,065.77 1,004.73 307.09 215.78 162.90 157.02 141.73 82.34 83.89 Gross Block 1,421.99 1,276.94 1,160.40 392.59 265.23 204.38 185.53 152.56 158.32 149.66 Accumulated Depreciation 301.90 211.17 155.66 85.50 49.45 41.47 28.51 10.83 75.99 65.77 Non Current Assets 1,219.47 1,341.11 1,264.88 379.56 510.27 453.38 288.15 208.72 133.81 128.13 Capital Work in Progress 0.00 19.51 5.78 0.00 2.99 5.77 0.00 0.00 0.00 0.00 Non Current Investment 36.65 36.65 36.65 3.54 129.78 131.73 30.50 39.12 39.12 35.89 Long Term Loans & Adv. 59.86 217.97 201.44 67.29 150.06 141.90 73.48 11.65 12.35 8.30 Other Non Current Assets 2.87 1.21 16.28 1.64 11.67 11.08 27.15 16.22 0.00 0.05 Current Assets 301.20 302.67 414.15 621.06 322.08 286.36 318.67 311.24 156.88 228.90 Current Investments 53.07 13.06 13.75 8.33 0.00 3.36 67.52 99.86 63.45 140.25 Inventories 33.89 41.27 47.01 38.12 17.46 19.65 14.96 9.01 9.51 9.66 Sundry Debtors 130.03 126.19 140.47 130.50 124.40 118.27 81.81 63.18 46.69 47.18 Cash & Bank 30.46 42.94 115.36 380.62 132.01 25.80 29.62 5.72 13.71 3.69 Other Current Assets 53.73 8.00 12.53 5.71 48.21 119.28 124.77 133.47 23.53 28.12 Short Term Loans & Adv. 47.85 71.20 85.03 57.79 45.05 107.52 120.55 130.65 21.21 27.41 Net Current Assets 38.07 12.17 66.26 399.03 168.41 103.24 154.31 78.43 85.39 183.38 Total Assets 1,520.67 1,643.78 1,679.03 1,000.62 832.35 739.74 606.82 519.96 290.69 357.03

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,096.16 988.23 886.20 706.60 523.50 418.54 414.77 323.17 265.00 361.28 Share Capital 10.25 10.24 10.23 10.22 10.13 10.04 9.54 9.54 9.54 9.86 Total Reserves 1,078.18 970.64 864.17 687.85 511.30 405.91 403.52 313.58 255.45 351.42 Non-Current Liabilities 373.45 416.66 492.88 110.93 194.63 141.74 147.66 15.72 1.06 9.51 Secured Loans 0.00 28.61 158.68 0.00 0.00 0.04 0.20 0.36 0.46 3.66 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.78 3.57 Long Term Provisions 186.97 190.65 173.80 43.70 156.34 140.38 145.88 3.15 3.01 3.03 Current Liabilities 275.48 302.83 363.85 240.17 210.20 241.37 232.97 151.85 105.02 74.95 Trade Payables 99.44 94.08 103.21 110.56 85.03 42.85 35.34 35.91 38.13 34.15 Other Current Liabilities 119.68 101.52 84.26 73.22 74.11 49.87 42.42 102.44 38.25 34.90 Short Term Borrowings 0.00 50.44 99.87 0.00 0.00 17.58 0.37 0.40 0.19 0.19 Short Term Provisions 56.35 56.80 76.52 56.40 51.05 131.07 154.84 13.11 28.44 5.71 Total Liabilities 1,748.21 1,710.20 1,744.90 1,059.16 929.99 803.08 809.77 511.72 391.34 468.31 Net Block 1,177.06 1,120.67 1,058.93 343.11 296.37 212.81 207.44 202.35 147.67 152.75 Gross Block 1,493.43 1,344.29 1,223.49 438.35 366.11 271.30 246.45 219.74 272.76 260.03 Accumulated Depreciation 316.37 223.63 164.56 95.24 69.74 58.49 39.01 17.38 125.08 107.28 Non Current Assets 1,402.77 1,369.61 1,289.47 414.50 492.20 381.48 367.09 226.61 165.87 166.72 Capital Work in Progress 0.00 19.51 5.78 0.00 2.99 5.77 0.00 0.95 0.56 0.36 Non Current Investment 1.75 1.75 1.75 1.75 1.75 2.27 1.76 7.79 1.76 3.05 Long Term Loans & Adv. 218.73 226.36 206.61 67.91 179.09 150.19 149.29 13.09 15.84 10.43 Other Non Current Assets 5.23 1.32 16.40 1.73 12.00 10.43 8.61 2.43 0.04 0.12 Current Assets 345.43 340.60 455.42 644.68 437.78 421.60 442.67 285.12 225.47 301.59 Current Investments 53.07 13.06 13.75 8.33 12.57 31.02 100.42 134.05 78.68 166.60 Inventories 38.69 44.59 51.11 40.55 24.40 26.10 21.19 14.13 17.62 18.33 Sundry Debtors 126.28 121.89 135.49 122.98 128.25 136.85 100.68 80.29 77.14 76.12 Cash & Bank 71.22 93.19 166.94 419.70 210.47 80.24 60.14 40.51 43.12 29.06 Other Current Assets 56.16 9.39 9.81 3.12 62.10 147.40 160.24 16.14 8.89 11.48 Short Term Loans & Adv. 48.71 58.48 78.33 50.00 57.46 135.02 155.50 12.14 6.29 9.24 Net Current Assets 69.96 37.76 91.57 404.50 227.58 180.24 209.70 133.26 120.45 226.64 Total Assets 1,748.20 1,710.21 1,744.89 1,059.18 929.98 803.08 809.76 511.73 391.34 468.31

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 269.01 237.74 244.04 236.23 156.13 56.43 74.48 61.54 57.34 41.60 PBT 157.41 178.95 271.55 242.13 139.99 149.19 135.26 118.44 110.04 64.94 Adjustment 116.52 96.11 54.34 71.33 49.41 3.80 4.78 -8.23 -30.52 6.74 Changes in Working Capital 22.34 6.72 -5.67 -22.16 14.34 -44.83 -18.92 -12.17 3.14 -9.64 Cash after chg. in Working capital 296.26 281.78 320.21 291.29 203.74 108.17 121.12 98.04 82.66 62.05 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.77 1.54 Tax Paid -27.26 -44.04 -76.17 -55.06 -47.61 -51.74 -46.64 -36.49 -26.10 -21.98 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -81.00 46.72 -738.21 59.42 -51.13 -4.35 18.86 -51.14 107.58 -35.25 Net Fixed Assets -125.54 -130.27 -773.59 -124.37 -58.07 -24.62 -32.97 5.76 -8.66 -11.95 Net Investments -40.01 0.69 -38.53 117.91 5.31 -37.07 40.96 -36.41 73.57 -26.90 Others 84.55 176.30 73.91 65.88 1.63 57.34 10.87 -20.49 42.67 3.60 Cash from Financing Activity -183.00 -287.87 171.97 -31.27 -46.37 -63.97 -81.58 -16.55 -154.99 -9.57 Net Cash Inflow / Outflow 5.01 -3.40 -322.20 264.38 58.63 -11.89 11.77 -6.14 9.92 -3.22 Opening Cash & Equivalents 24.09 27.49 347.68 83.30 8.80 20.69 8.93 10.62 3.36 6.58 Closing Cash & Equivalent 28.59 24.09 27.49 347.68 67.43 8.80 20.69 4.48 13.29 3.36

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 264.07 247.09 253.27 249.03 215.00 90.15 103.93 101.75 PBT 174.69 187.50 293.35 244.32 168.73 186.55 163.68 159.92 Adjustment 121.31 104.06 58.83 76.84 82.72 21.78 20.75 -3.00 Changes in Working Capital 5.45 7.11 -16.40 -15.31 27.97 -50.78 -22.92 -3.90 Cash after chg. in Working capital 301.45 298.67 335.79 305.86 279.43 157.55 161.51 153.02 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -37.38 -51.58 -82.51 -56.83 -64.43 -67.40 -57.57 -51.27 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -89.41 46.79 -737.57 61.70 -104.83 35.34 1.88 -85.78 Net Fixed Assets -125.54 -130.27 -773.59 -124.37 -58.07 -24.62 -32.97 Net Investments -40.01 0.69 -38.53 117.91 5.31 -37.07 40.96 Others 76.14 176.37 74.55 68.16 -52.07 97.03 -6.11 Cash from Financing Activity -181.20 -292.33 162.52 -32.69 -55.32 -118.15 -87.30 -17.30 Net Cash Inflow / Outflow -6.54 1.56 -321.78 278.04 54.85 7.35 18.51 -1.33 Opening Cash & Equivalents 68.83 65.98 386.59 107.17 51.37 43.47 25.51 26.83 Closing Cash & Equivalent 62.62 68.83 65.98 386.59 107.17 51.37 43.47 25.51

Financial Ratios

Consolidated /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 199.79 181.34 161.69 128.39 100.79 82.27 379.65 279.45 230.57 310.29 ROA 7.32% 8.36% 14.89% 19.93% 14.26% 15.07% 17.00% 19.56% 24.02% 12.79% ROE 11.87% 15.82% 26.90% 31.31% 24.28% 26.18% 30.45% 32.58% 29.57% 15.19% ROCE 18.02% 19.87% 33.60% 43.05% 31.74% 38.29% 43.80% 48.85% 41.25% 22.43% Fixed Asset Turnover 0.82 0.87 1.49 2.92 2.83 2.98 2.87 2.29 1.98 1.77 Receivable days 42.38 45.65 42.74 48.39 66.57 62.82 54.56 56.33 56.28 59.60 Inventory Days 12.43 15.11 13.43 10.55 10.18 10.87 9.02 9.50 11.50 12.91 Payable days 148.27 139.42 132.35 124.33 51.88 36.19 33.75 36.40 34.96 35.12 Cash Conversion Cycle -93.46 -78.66 -76.18 -65.39 24.87 37.50 29.83 29.43 32.82 37.39 Total Debt/Equity 0.00 0.09 0.31 0.00 0.00 0.04 0.00 0.00 0.02 0.03 Interest Cover 6.78 6.72 12.07 22.49 14.99 45.34 48.03 88.28 88.60 35.76

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 212.47 191.54 170.88 136.57 102.99 82.89 432.82 338.57 277.67 366.26 ROA 7.43% 8.30% 15.31% 18.43% 14.78% 15.51% 16.93% 23.75% 19.06% 14.48% ROE 12.42% 15.46% 27.31% 30.07% 27.33% 30.17% 30.38% 36.47% 26.16% 18.77% ROCE 18.73% 19.83% 34.39% 41.60% 37.90% 45.10% 45.22% 54.28% 40.06% 27.47% Fixed Asset Turnover 0.85 0.89 1.48 2.48 2.69 2.94 2.78 2.21 1.97 1.75 Receivable days 37.50 40.91 38.40 45.94 56.49 56.95 51.03 52.74 53.38 61.10 Inventory Days 12.59 15.21 13.62 11.88 10.76 11.34 9.96 10.64 12.52 14.71 Payable days 145.60 142.17 141.34 141.56 49.58 35.51 37.97 44.90 44.18 46.13 Cash Conversion Cycle -95.51 -86.05 -89.32 -83.74 17.67 32.78 23.02 18.48 21.71 29.69 Total Debt/Equity 0.00 0.08 0.30 0.00 0.00 0.04 0.00 0.00 0.03 0.04 Interest Cover 7.26 6.89 12.72 22.13 14.38 46.64 47.17 83.60 80.00 47.64

Top Investors:

hdfc mutual fund - hdfc focused 30 fund

uti value fund

kotak small cap fund

nippon life india trustee ltd-a/c nippon india small cap fund

sbi life insurance co. ltd

franklin india smaller companies fund

j p morgan funds

aditya birla sun life trustee private limited a/c aditya birla sun life flexi cap fund

sundaram mutual fund a/c sundaram services fund

canara robeco mutual fund a/c canara robeco small cap fund

Annual Reports:

News Update:

Metropolis Healthcare’s arm acquires entire business of ‘Dr. Ashok Kumar Sharma’s Scientific Pathology’
17th Jun 2025, 15:00 PM

The operations of the ‘Dr. Ashok Kumar Sharma’s Scientific Pathology' are now being carried out under Scientific Metropolis Pathology, effective June 16, 2025
Read More
Metropolis Healthcare’s arm to acquire Dehradun’s leading diagnostic chain
7th Apr 2025, 10:07 AM

Under the agreement, Metropolis Histoxpert Digital Services will acquire 100% ownership of DAPIC in an all-cash deal valued at Rs 35.01 crore
Read More
Metropolis Healthcare acquires Core Diagnostics
24th Mar 2025, 14:41 PM

Core Diagnostics becomes a wholly owned subsidiary of the company
Read More

Metropolis Healthcare Ltd.

Healthcare Services - Diagnostic

BSE: 542650 | NSE: METROPOLIS

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Metropolis Healthcare Ltd.

Healthcare Services - Diagnostic

BSE: 542650 | NSE: METROPOLIS

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: